Schedule 13G ownership disclosure

PROPANC BIOPHARMA INC

Security class unavailable · CUSIP: 74346N404

Event date: 2021-09-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,634,067
Percent of class
9.2500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-21-000414
Form type
SC 13G
Filer
Propanc Biopharma, Inc.
CIK
CIK 1517681
Filed
Sep 08, 2021
Reporting period
Sep 03, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub